Fatemeh Elahian

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 11

Top Venues

Epigenomics

Cell biology international

Journal of materials chemistry. B

Scientific reports

Shahrekord University of Medical Sciences

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Shahrekord University of Medical Sciences Sep 28 2014

Iran

Faculty member :: Medical Biotechnology

Zanjan University of Medical Sciences Sep 22 2010 - Sep 27 2014

Iran

Assistant Professor :: Pharmaceutical Biotechnology

Publications

Sayedeh Azimeh Hosseini, Mahdi Ghatrehsamani, Hajar Yaghoobi, Fatemeh Elahian, Seyed Abbas Mirzaei
Epigenetic disruption of histone deacetylase-2 accelerated apoptotic signaling and retarded malignancy in gastric cells. Epigenomics (2024)
Nayereh Abdali, Mohammad Nadipour Borujeni, Sayedeh Azimeh Hosseini, Rahim Malekzadeh, Marzieh Abolhasani, Seyed Abbas Mirzaei, Fatemeh Elahian
Paynantheine more effectively reverses multidrug resistance in malignant EPG85.257RDB and MCF7MX cells than morphine and speciociliatine. Cell biology international (2024)
Fatemeh Karimzadeh, Elahe Soltani Fard, Akram Nadi, Rahim Malekzadeh, Fatemeh Elahian, Seyed Abbas Mirzaei
Advances in skin gene therapy: utilizing innovative dressing scaffolds for wound healing, a comprehensive review. Journal of materials chemistry. B 12 (25) (2024)
Sayedeh Azimeh Hosseini, Mahdi Ghatrehsamani, Hajar Yaghoobi, Fatemeh Elahian, Seyed Abbas Mirzaei
Epigenetic disruption of histone deacetylase-2 accelerated apoptotic signaling and retarded malignancy in gastric cells. Epigenomics 16 (5) (2024)
Nayereh Abdali, Mohammad Nadipour Borujeni, Sayedeh Azimeh Hosseini, Rahim Malekzadeh, Marzieh Abolhasani, Seyed Abbas Mirzaei, Fatemeh Elahian
Paynantheine more effectively reverses multidrug resistance in malignant EPG85.257RDB and MCF7MX cells than morphine and speciociliatine. Cell biology international 48 (6) (2024)
Fatemeh Karimzadeh, Elahe Soltani Fard, Akram Nadi, Rahim Malekzadeh, Fatemeh Elahian, Seyed Abbas Mirzaei
Advances in skin gene therapy: utilizing innovative dressing scaffolds for wound healing, a comprehensive review. Journal of materials chemistry. B (2024)
Sayedeh Azimeh Hosseini, Mahdi Ghatrehsamani, Hajar Yaghoobi, Fatemeh Elahian, Seyed Abbas Mirzaei
Epigenetic disruption of histone deacetylase-2 accelerated apoptotic signaling and retarded malignancy in gastric cells. Epigenomics 16 (5) (2024)
Fatemeh Elahian, Maryam Garshasbi, Zahra Mehri Asiabar, Neda Gholamian Dehkordi, Alireza Yazdinezhad, Seyed Abbas Mirzaei
Ecotypic Variations Affected the Biological Effectiveness of Thymus daenensis Celak Essential Oil. Evidence-based complementary and alternative medicine : eCAM 2021 (2021)
Zahra Arshadi, Sayedeh Azimeh Hosseini, Daryoush Fatehi, Seyed Abbas Mirzaei, Fatemeh Elahian
Butylcycloheptylprodigiosin and undecylprodigiosin are potential photosensitizer candidates for photodynamic cancer therapy. Molecular biology reports 48 (8) (2021)
Razieh Heidari, Pegah Khosravian, Seyed Abbas Mirzaei, Fatemeh Elahian
siRNA delivery using intelligent chitosan-capped mesoporous silica nanoparticles for overcoming multidrug resistance in malignant carcinoma cells. Scientific reports 11 (1) (2021)
Neda Gholamian Dehkordi, Seyed Abbas Mirzaei, Fatemeh Elahian
Pharmacodynamic mechanisms of anti-inflammatory drugs on the chemosensitization of multidrug-resistant cancers and the pharmacogenetics effectiveness. Inflammopharmacology 29 (1) (2020)

Fatemeh Elahian.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Fatemeh Elahian